.µÚÒ»Õ Ð÷ÂÛ Ò»¡¢Ãû´Ê½âÊÍ
1. Ò©¼Áѧ 2. Ò©µä3. ´¦·½4. GMP 5. GLP 6. DDS 7. OTC 8. USP 9. ÖƼÁ10. ¼ÁÐÍ11. ÈÜÒºÐÍ·Öɢϵͳ 12. Èé¼ÁÐÍ·Öɢϵͳ 13. »ìÐüÐÍ·Öɢϵͳ 14. ·Ç賦µÀ¸øÒ©ÖƼÁ 15. ¹ÌÌåÐÍ·Öɢϵͳ 16. ÆøÌåÐÍ·Öɢϵͳ ¶þ¡¢Ë¼¿¼Ìâ
1. Ò©¼ÁѧµÄ·Ö֧ѧ¿ÆÓÐÄÄЩ£¿ÊÔ·Ö±ð½âÊ͸÷ѧ¿ÆµÄ¶¨Òå¡£ 2. Ò©¼ÁѧÑо¿µÄÖ÷ÒªÈÎÎñÊÇʲô£¿ 3. ÏÖ´úÒ©¼ÁѧµÄºËÐÄÄÚÈÝÊÇʲô£¿
4. Ä¿Ç°°ä²¼µÄÖйúÒ©µäºÍ¹úÍâÒ©µäÓÐÄÄЩ£¿×îа汾ÊÇÄÄÒ»°æ£¿ 5. Ò©Îï¼ÁÐÍ¿É·ÖΪ¼¸ÀࣿÊÔ·Ö±ðÐðÊö¡£ 6. ¼ÁÐ͵ÄÖØÒªÐÔÖ÷Òª°üÀ¨ÄÄЩ£¿
7. Ò©ÎïÖƼÁºÍ¼ÁÐ͵ķ¢Õ¹¿É·ÖΪÄÄËĸöʱ´ú£¿ÊÔ·Ö±ðÐðÊö¡£ ²Î¿¼´ð°¸£º Ò»¡¢Ãû´Ê½âÊÍ£º
1. Ò©¼Áѧ£ºpharmaceutics£¬pharmacy£¬ÊÇÑо¿Ò©ÎïÖƼÁµÄ»ù±¾ÀíÂÛ¡¢´¦·½Éè¼Æ¡¢ÖƱ¸¹¤ÒÕ¡¢ÖÊÁ¿¿ØÖƺͺÏÀíʹÓõÈÄÚÈݵÄ×ÛºÏÐÔÓ¦Óü¼Êõ¿Æѧ¡£
2. Ò©µä£ºpharmacopoeia£¬ÊÇÒ»¸ö¹ú¼Ò¼ÇÔØÒ©Æ·±ê×¼¡¢¹æ¸ñµÄ·¨µä£¬Ò»°ãÓɹú¼ÒÒ©µäίԱ»á×éÖ¯±à׫£¬²¢ÓÉÕþ¸®°ä²¼¡¢Ö´ÐУ¬¾ßÓз¨ÂÉÔ¼ÊøÁ¦¡£ 3. ´¦·½£ºÏµÖ¸Ò½ÁƺÍÉú²ú²¿ÃÅÓÃÓÚÒ©¼Áµ÷ÖƵÄÒ»ÖÖÖØÒªÊéÃæÎļþ¡£
4. GMP£ºÊÇGood Manufacturing PracticeµÄËõд£¬ÖÐÎÄÊÇ¡¶Ò©Æ·Éú²úÖÊ
Á¿¹ÜÀí¹æ·¶¡·¡£GMPÊÇÒ©Æ·Éú²ú¹ý³ÌÖУ¬ÓÿÆѧ¡¢ºÏÀí¡¢¹æ·¶»¯µÄÌõ¼þºÍ·½·¨À´±£Ö¤Éú²úÓÅÁ¼Ò©Æ·µÄÒ»ÕûÌ×ϵͳµÄ¡¢¿ÆѧµÄ¹ÜÀí¹æ·¶£¬ÊÇÒ©Æ·Éú²úºÍÖÊÁ¿¹ÜÀíµÄ»ù±¾×¼Ôò¡£
5. GLP£ºÊÇGood Laboratory PracticeµÄ¼ò³Æ£¬¼´¡¶Ò©Îï·ÇÁÙ´²Ñо¿ÖÊÁ¿¹ÜÀí¹æ·¶¡·¡£
6. DDS£ºÒ©Îï´«µÝϵͳDrug Delivery System£¬ÓÖ³ÆÒ©Îï¸øҩϵͳ£¬ÏµÖ¸ÈËÃÇÔÚ·ÀÖμ²²¡µÄ¹ý³ÌÖÐËù²ÉÓõĸ÷ÖÖÖÎÁÆÒ©ÎïµÄ²»Í¬¸øÒ©ÐÎʽ¡£
7. OTC£º·Ç´¦·½Ò©¼´²»Ðèƾִҵҽʦ»òÖ´ÒµÖúÀíҽʦµÄ´¦·½£¬Ïû·ÑÕß¿ÉÒÔ×ÔÐÐÅжϹºÂòºÍʹÓõÄÒ©Æ·¡£ÔÚ¹úÍâÓÖ³ÆΪ¡°¿ÉÔÚ¹ñ̨ÉÏÂòµ½µÄÒ©Î Over The Counter£¬OTCÒѳÉΪȫÇòͨÓõķǴ¦·½Ò©µÄ¼ò³Æ¡£
8. USP£ºÃÀ¹úÒ©µä£¬ÊÇÃÀ¹ú¼ÇÔØÒ©Æ·±ê×¼¡¢¹æ¸ñµÄ·¨µä£¬Óɹú¼ÒÒ©µäίԱ»á×éÖ¯±à׫£¬²¢ÓÉÕþ¸®°ä²¼¡¢Ö´ÐУ¬¾ßÓз¨ÂÉÔ¼ÊøÁ¦¡£
9. ÖƼÁ£ºÒÔ¼ÁÐÍÖƳɵľßÌåÒ©Æ·³ÆΪҩÎïÖƼÁ (pharmaceutical preparations, pharmaceuticals)£¬¼ò³ÆÖƼÁ¡£ÖƼÁµÄÑÐÖƹý³ÌÒ²³ÆÖƼÁ (pharmaceutical manufacturing)
10. ¼ÁÐÍ£ºdosage form£¬°ÑÒ½Ò©Æ·ÒÔ²»Í¬¸øÒ©·½Ê½ºÍ²»Í¬¸øÒ©²¿Î»µÈΪĿµÄÖƳɵIJ»Í¬¡°ÐÎ̬¡±£¬¼ò³Æ¼ÁÐÍ¡£
11. ÈÜÒºÐÍ·ÖɢϵͳÖƼÁ£ºÒ©ÎïÒÔ·Ö×Ó»òÀë×Ó״̬£¨ÖʵãµÄÖ±¾¶¡Ü1nm£©·ÖÉ¢ÓÚ·ÖÉ¢½éÖÊÖÐËùÐγɵľùÔÈ·ÖÉ¢Ìåϵ£¬Ò²³ÆµÍ·Ö×ÓÈÜÒº¡£
12. Èé¼ÁÐÍ·ÖɢϵͳÖƼÁ£ºÓÍÀàÒ©Îï»òÒ©ÎïÓÍÈÜÒºÒÔÒºµÎ״̬·ÖÉ¢ÔÚ·ÖÉ¢½éÖÊÖÐËùÐγɵķǾùÔÈ·ÖÉ¢Ìåϵ¡£
13. »ìÐüÐÍ·ÖɢϵͳÖƼÁ£º¹ÌÌåÒ©ÎïÒÔ΢Á£×´Ì¬·ÖÉ¢ÔÚ·ÖÉ¢½éÖÊÖÐËùÐγɵķǾù
ÔÈ·ÖÉ¢Ìåϵ¡£
14. ·Ç賦µÀ¸øÒ©ÖƼÁ£º³ý¿Ú·þ¸øҩ;¾¶ÒÔÍâµÄËùÓÐÆäËû¼ÁÐÍ¡£ 15. ¹ÌÌåÐÍ·Öɢϵͳ£º¹ÌÌåÒ©ÎïÒÔ¾Û¼¯Ìå״̬´æÔڵķÖÉ¢Ìåϵ¡£
16. ÆøÌåÐÍ·Öɢϵͳ£ºÒºÌå»ò¹ÌÌåÒ©ÎïÒÔ΢Á£×´Ì¬·ÖÉ¢ÔÚÆøÌå·ÖÉ¢½éÖÊÖÐËùÐγɵķÖÉ¢Ìåϵ¡£ ¶þ¡¢Ë¼¿¼Ìâ
1. Ò©¼ÁѧµÄ·Ö֧ѧ¿ÆÓÐÄÄЩ£¿ÊÔ·Ö±ð½âÊ͸÷ѧ¿ÆµÄ¶¨Òå¡£
´ð£º·Ö֧ѧ¿Æ£º¹¤ÒµÒ©¼Áѧ¡¢ÎïÀíÒ©¼Áѧ¡¢Ò©Óø߷Ö×Ó²ÄÁÏѧ¡¢ÉúÎïÒ©¼Áѧ¡¢Ò©ÎﶯÁ¦Ñ§¡¢ÁÙ´²Ò©¼Áѧ¡¢Ò½Ò©Ç鱨ѧµÈ¡£
¢Å ¹¤ÒµÒ©¼Áѧ(industrial pharmaceutics) ÊÇÀûÓÃÈÜÒºµÄÐγÉÀíÂÛ¡¢·ÛÌåѧ¡¢Á÷±äѧ¡¢½çÃ滯ѧµÈµÄÑо¿ÊÖ¶ÎÑо¿¼ÁÐͼ°ÖƼÁµ¥Ôª²Ù×÷µÄ»ù±¾ÀíÂÛ¡¢¹¤ÒÕ¼¼Êõ¡¢Éú²úÉ豸ºÍÖÊÁ¿¹ÜÀíµÄѧ¿Æ¡£
¢Æ ÎïÀíÒ©¼Áѧ(physical pharmaceutics) ÊÇÎïÀíÒ©¼ÁѧÊÇÔËÓÃÎïÀí»¯Ñ§ÔÀí¡¢·½·¨ºÍÊֶΣ¬Ñо¿Ò©¼ÁѧÖÐÓйؼÁÐÍ¡¢ÖƼÁµÄ´¦·½Éè¼Æ¡¢ÖƱ¸¹¤ÒÕ¡¢ÖÊÁ¿¿ØÖƵÈÄÚÈݵıßԵѧ¿Æ¡£
¢Ç Ò©Óø߷Ö×Ó²ÄÁÏѧ(Polymers in Pharmaceutics) Ö÷Òª½éÉÜÒ©¼ÁѧµÄ¼ÁÐÍÉè¼ÆºÍÖƼÁ´¦·½Öг£ÓõĺϳɺÍÌìÈ»¸ß·Ö×Ó²ÄÁϵĽṹ¡¢ÖƱ¸¡¢ÎïÀí»¯Ñ§ÌØÕ÷ÒÔ¼°Æ书ÄÜÓëÓ¦Óá£
¢È ÉúÎïÒ©¼Áѧ (biopharmaceutics) ÊÇÑо¿Ò©ÎïÔÚÌåÄÚµÄÎüÊÕ¡¢·Ö²¼¡¢´úлÓëÅÅйµÄ»úÀí¼°¹ý³Ì£¬²ûÃ÷Ò©ÎïÒòËØ¡¢¼ÁÐÍÒòËغÍÉúÀíÒòËØÓëҩЧ֮¼ä¹ØϵµÄ±ßԵѧ¿Æ¡£
¢É Ò©ÎﶯÁ¦Ñ§ (pharmacokinetics) ÊDzÉÓÃÊýѧµÄ·½·¨£¬Ñо¿Ò©ÎïÔÚÌåÄÚµÄÎü
ÊÕ¡¢·Ö²¼¡¢´úлÓëÅÅйµÄ¾Ê±¹ý³ÌÓëҩЧ֮¼ä¹ØϵµÄѧ¿Æ£¬¶ÔÖ¸µ¼ÖƼÁÉè¼Æ¡¢¼ÁÐ͸ĸ°²È«ºÏÀíÓÃÒ©µÈÌṩÁ¿»¯Ö¸±ê¡£
¢Ê ÁÙ´²Ò©¼Áѧ£¨Clinical Pharmaceutics£©ÊÇÒÔ»¼ÕßΪ¶ÔÏó£¬Ñо¿ºÏÀí¡¢ÓÐЧ¡¢°²È«ÓÃÒ©µÈ£¬ÓëÁÙ´²ÖÎÁÆѧ½ôÃÜÁªÏµµÄÐÂѧ¿Æ£¬Òà³Æ(¹ãÒåµÄ)µ÷¼Áѧ»òÁÙ´²Ò©Ñ§¡£ ¢Ë Ò½Ò©Ç鱨ѧ£¨Drug informatics£©ÊÇÊÕ¼¯ºÍÆÀ¼ÛÅÓ´óµÄÓëÒ½Ò©Æ·Ïà¹ØµÄÇ鱨£¬ÒÔ¸÷ÖÖÇ鱨ΪÒÀ¾Ý̽¾¿Ò©ÎïÖÎÁƵÄÒÀ¾Ý£¬Ä±ÇóÒ½Ò©Æ·µÄ×îÊÊÒË·½°¸µÄѧ¿Æ¡£ 2. Ò©¼ÁѧÑо¿µÄÖ÷ÒªÈÎÎñÊÇʲô£¿ ´ð£º¢Å Ò©¼Áѧ»ù±¾ÀíÂÛµÄÑо¿ ¢Æ мÁÐ͵ÄÑо¿Ó뿪·¢ ¢Ç м¼ÊõµÄÑо¿Ó뿪·¢ ¢È ÐÂÒ©Óø¨ÁϵÄÑо¿Ó뿪·¢ ¢É ÖÐҩмÁÐ͵ÄÑо¿Ó뿪·¢ ¢Ê ÉúÎï¼¼ÊõÒ©ÎïÖƼÁµÄÑо¿ºÍ¿ª·¢ ¢Ë ÖƼÁлúеºÍÐÂÉ豸µÄÑо¿Ó뿪·¢ 3. ÏÖ´úÒ©¼ÁѧµÄºËÐÄÄÚÈÝÊÇʲô£¿
´ð£º½«ÔÁÏÒ©Î»¯Ñ§Ò©¡¢ÖÐÒ©¡¢ÉúÎï¼¼ÊõÒ©ÎÖƱ¸³ÉÊÊÓÃÓÚ¼²²¡µÄÖÎÁÆ¡¢Ô¤·À»òÕï¶ÏµÄÒ½Ò©Æ·£¨medicines, drugs£©
4. Ä¿Ç°°ä²¼µÄÖйúÒ©µäºÍ¹úÍâÒ©µäÓÐÄÄЩ£¿×îа汾ÊÇÄÄÒ»°æ£¿
´ð£ºÖлªÈËÃñ¹²ºÍ¹úÒ©µäCPÓÐ1953Äê°æ¡¢1963Äê°æ¡¢1977Äê°æ¡¢1985Äê°æ¡¢1990Äê°æ¡¢1995Äê°æ¡¢2000Äê°æ¡¢2005Äê°æ¡£×îаæΪ2010Äê°æ£¬2010Äê7ÔÂ1ÈÕÆðÕýʽʵʩ¡£
ÃÀ¹úÒ©µäUSP£¬×îаæ32°æUSP32-NF27 (2009Äê)¡£